COMPARATIVE EFFECTIVENESS OF FIXED-DOSE COMBINATIONS OF LISINOPRIL/AMLODIPINE AND ENALAPRIL/HYDROCHLOROTHIAZIDE
https://doi.org/10.15829/1728-8800-2013-2-25-29
Abstract
Aim. To compare clinical effectiveness and tolerability of the fixed-dose combinations of lisinopril/amlodipine (Ekvator) and enalapril/hydrochlorothiazide (Co-renitec) in high and very-high risk patients with Stage I–II arterial hypertension, whose blood pressure (BP) levels were not normalised during the preceding antihypertensive monotherapy.
Material and methods. This blind, randomised (envelope method), parallel study included 27 patients in each group. For 6 months, participants received the first medication (1 tablet a day, in the morning). After the 14-day wash-out phase, they were switched to another medication and received either Ekvator (lisinopril 10 mg plus amlodipine 5 mg) or Co-renitec (enalapril 20 mg plus hydrochlorothiazide 12,5 mg).
Results. After 6 months of the treatment, more than 78% of the patients receiving Ekvator achieved target BP levels, in contrast to the participants receiving Co-renitec. Moreover, the treatment with Ekvator was associated with a significant reduction in the myocardial thickness of the posterior left ventricular wall and the carotid-femoral pulse wave velocity, as well as with a significant improvement in lipid metabolism parameters.
Conclusion. Ekvator was more effective than Co-renitec in terms of antihypertensive activity, left ventricular hypertrophy reduction, and arterial elasticity improvement, as well as trough/peak ratio improvement.
About the Authors
S. V. Nedogoda
Volgograd State Medical University, Volgograd
Russian Federation
Russian Federation
E. V. Chumachek
Volgograd State Medical University, Volgograd
Russian Federation
Russian Federation
A. A. Ledyaeva
Volgograd State Medical University, Volgograd
Russian Federation
Russian Federation
A. V. Tsoma
Volgograd State Medical University, Volgograd
Russian Federation
Russian Federation
A. S. Salasyuk
Volgograd State Medical University, Volgograd
Russian Federation
Russian Federation
References
1. Recommendations about prevention, diagnostics and treatment of arterial hypertension. Arterial hypertension 2001; 7 (1): Appendix. Russian (Рекомендации по профилактике, диагностике и лечению артериальной гипертензии. Артериальная гипертензия 2001; 7 (1): (Приложение)).
2. The Russian medical society on an arterial hypertension (RMOAG), the All-Russian Scientific Organization of Cardiologists (ARSOC). Diagnostics and treatment of arterial hypertension. Russian recommendations (the fourth revision), 2010. System Hypertensia magazine 2010; 3. Russian (Российское медицинское общество по артериальной гипертонии (РМОАГ), Всероссийское научное общество кардиологов (ВНОК). Диагностика и лечение артериальной гипертензии. Российские реко- мендации (четвертый пересмотр) 2010. Ж Системные гипертензии 2010; 3).
3. National recommendations about cardiovascular prevention. Cardiovascular therapy and prevention 2011; 10 (6) Appendix 2). Russian (Национальные рекомендации по кардиоваскулярной профилактике. Кардиоваскулярная терапия и профилактика 2011; 10 (6) Приложение 2)).
4. 2003 European Society of Hypertension — European Society of Cardiology. Guidelines for the management of arterial Hypertension. Guidelines Committee. J of Hypertension 2003; 21: 1011–53.
5. Chalmers J, Castaigne A, Morgan T, et al. Long term efficacy of a new fixed very low dose angiotensin-converting enzyme-inhibitor/diuretic combination as first line therapy in elderly hypertensive patients. J Hypertens 2000; 18: 327–37.
6. Chen JMH, Heran BS, Wright JM, et al. Blood pressure lowering efficacy of diuretics as secondline therapy for primary hypertension. Cochrane Database Syst Rev 2009; 4: CD007187.
7. Chobanian AV. Major improvement in the control of hypertension in Canada. CMAJ 2011; available at: http://www.cmaj.ca.
8. Chrysant SG. Using fixed-dose combination therapies to achieve blood pressure goals. Clin Drug Investig 2008; 28 (11): 713–34.
9. Egan BM, Bandyopadhyay D., Shaftman1 S.R. et al. The impact of initial treatment of hypertension on control in the first year: Comparison of initial monotherapy, free-dose combination, and fixed-dose combinations. ASH 2011; Abstract PO-142
10. Silva PM. Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/lisinoprile. Clin Drug Investig 2010; 30 (9): 625–41.
11. Nedogoda SV, Chumachеk EV, Ledyaeva AA, et al. Increase of efficiency of hypotensive therapy when using the fixed combinations. Arterial hypertension 2011; 6: 514–7. Russian (Недогода С. В., Чумачек Е. В., Ледяева А. А., и др. Повышение эффективности гипотензивной терапии при использовании фиксированных комбинаций. Артериальная гипертензия 2011; 6: 514–7).
Review
For citations:
Nedogoda S.V., Chumachek E.V., Ledyaeva A.A., Tsoma A.V., Salasyuk A.S. COMPARATIVE EFFECTIVENESS OF FIXED-DOSE COMBINATIONS OF LISINOPRIL/AMLODIPINE AND ENALAPRIL/HYDROCHLOROTHIAZIDE. Cardiovascular Therapy and Prevention. 2013;12(2):25-29. (In Russ.) https://doi.org/10.15829/1728-8800-2013-2-25-29
Views:
22525
Email this article 
